Chengdu Sino-Clone Organ Biotechnology, Co., Ltd
中科奥格
Chengdu Sino-Clone Organ Biotechnology, Co., Ltd
Materials/Deep Tech
Founded in 2018, Zhongke Auge focuses on xenogeneic organ transplantation and medical pigs for disease models, addressing clinical organ shortages and demand for large-animal models. It operates an advanced innovation platform spanning gene-edited pigs through preclinical trials.
Latest round: Series A Extension+ (2025)
Source: ChinaBulls — chinabulls.com
Last updated 2025-09-01
Funding history
Request access to view this section.
Investors
Request access to view this section.
HQ & website
Request access to view this section.
Tags
Request access to view this section.